Survival for patients with invasive cutaneous melanoma among ethnic groups: The effects of socioeconomic status and treatment

Journal of Clinical Oncology

Volumn 26, Issue 1, 2008, Pages 66-75

  Zell, Jason A ^a   Cinar, Pelin ^a   Mobasher, Mehrdad ^a   Ziogas, Argyrios ^a   Meyskens Jr , Frank L ^a   Anton Culver, Hoda ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; SOCIAL STATUS; SOCIOECONOMICS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CALIFORNIA; COHORT STUDIES; ETHNIC GROUPS; FEMALE; HUMANS; MALE; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SEER PROGRAM; SKIN NEOPLASMS; SOCIAL CLASS; SOCIOECONOMIC FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 37849044639     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.12.3604     Document Type: Article

References (46)

1. Rhodes AR, Weinstock MA, Fitzpatrick TB, Mihm MC, Sober AJ: Risk-Factors for Cutaneous Melanoma - A Practical Method of Recognizing Pre-disposed Individuals. JAMA 258:3146-3154, 1987
2. Cress RD, Holly EA: Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: An analysis of California Cancer Registry data, 1988-93. Cancer Causes Control 8:246-252, 1997
3. Bellows CF, Belafsky P, Fortgang IS, Beech DJ: Melanoma in African-Americans: Trends in biological behavior and clinical characteristics over two decades. J Surg Oncol 78:10-16, 2001
4. Crowley NJ, Dodge R, Vollmer RT, Seigler HF: Malignant-melanoma in black Americans: A Trend Toward Improved Survival. Arch Surg 126:1359-1365, 1991
5. Hu S, Parker DF, Thomas AG, Kirsner RS: Advanced presentation of melanoma in African Americans: The Miami-Dade County experience. J Am Acad Dermatol 51:1031-1032, 2004
6. Tsai T, Vu C, Henson DE: Cutaneous, ocular, and visceral melanoma in African Americans and Caucasians. Melanoma Res 15:213-217, 2005
7. Byrd KM, Wilson DC, Hoyler SS, Peck GL: Advanced presentation of melanoma in African Americans. J Am Acad Dermatol 50:21-24, 2004
8. Swan MC, Hudson DA: Malignant melanoma in South Africans of mixed ancestry: A retrospective analysis. Melanoma Res 13:415-419, 2003
9. Chang AE, Karnell LH, Menck HR: The National Cancer Data Base report on cutaneous and noncutaneous melanoma: A summary of 84,836 cases from the past decade. Cancer 83:1664-1678, 1998
10. Cormier JN, Xing Y, Ding MC, et al: Ethnic differences among patients with cutaneous melanoma. Arch Intern Med 166:1907-1914, 2006
11. Hemminki K, Li XJ: Level of education and the risk of cancer in Sweden. Cancer Epidemiol Biomarkers Prev 12:796-802, 2003
12. Hemminki K, Zhang H, Czene K: Socioeconomic factors in cancer in Sweden. Int J Cancer 105:692-700, 2003
13. Goodman KJ, Bible ML, London S, Mack TM: Proportional melanoma incidence and occupation among white males in Los-Angeles-County (California, United-States). Cancer Causes Control 6:451-459, 1995
14. Epstein DS, Lange JR, Gruber SB, Mofid M, Koch SE: Is physician detection associated with thinner melanomas? JAMA 281:640-643, 1999
15. Roetzheim RG, Pal N, Van Durme DJ, et al: Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection. J Am Acad Dermatol 43:211-218, 2000
16. Roetzheim RG, Pal N, Tennant C, et al: Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 91:1409-1415, 1999
17. Luke CG, Coventry BJ, Foster-Smith EJ, Roder DM: A critical analysis of reasons for improved survival from invasive cutaneous melanoma. Cancer Causes Control 14:871-878, 2003
18. Coleman MP, Rachet B, Woods LM, et al: Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer 90:1367-1373, 2004
19. Parikh-Patel A, Bates JH, Campleman S: Colorectal cancer stage at diagnosis by socioeconomic and urban/rural status in California, 1988-2000. Cancer 107:1189-1195, 2006
20. Cancer Reporting in California: Standards for Automated Reporting, in California Cancer Reporting System Standards, Volume II. Sacramento, CA, California Department of Health Services, Cancer Surveillance Section, 1997
21. Cancer Reporting in California: Data Standards for Regional Registries and Calfornia Cancer Registry, in California Cancer Reproting Standards, Volume III. Sacramento, CA, California Department of Health Services, Cancer Surveillance Section, 1997
22. Cancer Reporting in California: Abstracting and Coding Procedures for Hospitals, in California Cancer Reporting System Standards, Volume I. Sacramento, CA, California Department of Health Services, Cancer Surveillance Section, 1997
23. Cancer Reporting in California: Reporting Procedures for Physicians, in California Cancer Reporting System Standards, Volume IV. Sacramento, CA, California Department of Health Services, Cancer Surveillance Section, 1998
24. California Cancer Registry: How complete are California Cancer Registry data? http://www.ccrcal.org/questions.html
25. Fritz A, Percy C, Jack A, et al: International Classification of Diseases for Oncology (ed 3). Geneva, Switzerland, World Health Organization, 2000
26. Balch CM, Soong SJ, Gershenwald JE, et al: Prognostic factors analysis of 17,600 patients with melanoma: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19:3622-3634, 2001
27. Balch CM, Buzaid AC, Soong SJ, et al: Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635-3648, 2001
28. Gimotty PA, Botbyl J, Soong SJ, Guerry D: A population-based validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 23:8065-8075, 2005
29. Yost K, Perkins C, Cohen R, Morris C, Wright W: Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 12:703-711, 2001
30. Morris CR, Snipes KP, Schlag R, Wright WE: Sociodemographic factors associated with prostatectomy utilization and concordance with the physician data query for prostate cancer (United States). Cancer Causes Control 10:503-511, 1999
31. Cress RD, O'Malley CD, Leiserowitz GS, Campleman SL: Patterns of chemotherapy use for women with ovarian cancer: A population-based study. J Clin Oncol 21:1530-1535, 2003
32. Ou SI, Zell JA, Ziogas A, Anton-Culver H: Epidemiology of nasopharyngeal carcinoma (NPC) in California: Survival advantage of Chinese WHO Type 1 NPC patients resulted in Asian ethnicity as an independent and favorable prognostic factor of survival for NPC patients as a whole and for patients with the WHO histologic type 1. J Clin Oncol 24:283S, 2006 (suppl; asbtr 5514)
33. Zell JA, Rhee JM, Ziogas A, Lipkin SM, Anton-Culver H: Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev 16:546-552, 2007
34. Hirschman J, Whitman S, Ansell D: The black: white disparity in breast cancer mortality: The Example of Chicago. Cancer Causes Control 18:323-333, 2007
35. Howe HL, Wu XC, Ries LAG, et al: Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among US Hispanic/Latino populations. Cancer 107:1711-1742, 2006
36. Albino AP, Nanus DM, Mentle IR, et al: Analysis of Ras Oncogenes in Malignant-Melanoma and Precursor Lesions: Correlation of Point Mutations with Differentiation Phenotype. Oncogene 4:1363-1374, 1989
37. Davies H, Bignell GR, Cox C, et al: Mutations of the BRAF gene in human cancer. Nature 417:949-954, 2002
38. Curtin JA, Fridlyand J, Kageshita T, et al: Distinct sets of genetic alterations in melanoma. N Engl J Med 353:2135-2147, 2005
39. Curtin JA, Busam K, Pinkel D, Bastian BC: Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 24:4340-4346, 2006
40. Landi MT, Bauer J, Pfeiffer RM, et al: MC1R germline variants confer risk for BRAF-mutant melanoma. Science 313:521-522, 2006
41. Green A, McCredie M, MacKie R, et al: A case-control study of melanomas of the soles and palms (Australia and Scotland). Cancer Causes Control 10:21-25, 1999
42. Hu S, Ma FC, Collado-Mesa F, Kirsner RS: UV radiation, latitude, and melanoma in US Hispanics and blacks. Arch Dermatol 140:819-824, 2004
43. Eide MJ, Weinstock MA: Association of UV index, latitude, and melanoma incidence in non-white populations: US surveillance, epidemiology, and end results (SEER) program, 1992 to 2001. Arch Dermatol 141:477-481, 2005
44. Meyskens FL, Farmer PJ, Anton-Culver H: Etiologic pathogenesis of melanoma: A unifying hypothesis for the missing attributable risk. Clinical Cancer Res 10:2581-2583, 2004
45. Meyskens FL, Farmer P, Fruehauf JP: Redox regulation in human melanocytes and melanoma. Pigment Cell Res 14:148-154, 2001
46. Meyskens FL, Farmer PJ, Anton-Culver H: Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev 14:293, 2005